| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.03B | 29.52B | 30.48B | 28.28B | 24.53B | 25.69B |
| Gross Profit | 8.42B | 8.42B | 8.65B | 7.43B | 6.29B | 6.85B |
| EBITDA | 2.33B | 2.52B | 2.87B | 2.17B | 1.32B | 1.87B |
| Net Income | 1.54B | 1.59B | 1.86B | 1.62B | 735.00M | 1.03B |
Balance Sheet | ||||||
| Total Assets | 28.32B | 29.89B | 30.92B | 28.85B | 26.24B | 25.23B |
| Cash, Cash Equivalents and Short-Term Investments | 9.24B | 9.65B | 9.58B | 7.48B | 6.50B | 5.80B |
| Total Debt | 1.19B | 854.00M | 837.00M | 792.00M | 999.00M | 995.00M |
| Total Liabilities | 7.91B | 8.92B | 10.73B | 10.41B | 9.10B | 8.70B |
| Stockholders Equity | 20.41B | 20.97B | 20.19B | 18.44B | 17.14B | 16.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 858.00M | 2.40B | 1.07B | 1.08B | 1.25B |
| Operating Cash Flow | 0.00 | 1.82B | 2.66B | 1.17B | 1.29B | 1.47B |
| Investing Cash Flow | 0.00 | -950.00M | -49.00M | 327.00M | -315.00M | -231.00M |
| Financing Cash Flow | 0.00 | -802.00M | -513.00M | -511.00M | -278.00M | -243.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥13.22B | 5.32 | ― | 3.58% | -3.74% | 3.99% | |
67 Neutral | ¥907.14B | 9.02 | 0.85% | 2.36% | -0.03% | -89.02% | |
67 Neutral | ¥106.11B | 8.48 | 2.57% | 3.57% | 2.69% | 1.74% | |
66 Neutral | ¥130.79B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.82B | 4.98 | ― | 4.13% | 2.76% | -10.23% | |
52 Neutral | ¥481.94B | 16.11 | 1.44% | 4.80% | 0.68% | ― |